Global pivotal study of BGB-A317 in Solid tumor.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Tislelizumab (Primary)
- Indications Solid tumours
- Focus Registrational; Therapeutic Use
- 07 Jul 2017 New trial record
- 05 Jul 2017 According to a celgene corporation media release, this trial is planned for initiation in 2018.